Education
About Us
Working with TipRanks
Follow Us
PYC Therapeutics Limited (AU:PYC)
ASX:PYC
PYC Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PYC Stock 12 Month Forecast
Average Price Target
AU$2.85
▲(137.50% Upside)
| Highest Price TargetAU$2.85 | Average Price TargetAU$2.85 | Lowest Price TargetAU$2.85 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
AU$2.85
Buy
137.50%
Upside
Reiterated
12/08/25
Bell Potter
AU$2.3
Buy
91.67%
Upside
Reiterated
09/08/25
Bloom Burton
AU$4
Buy
233.33%
Upside
Reiterated
04/30/25
Unknown Analyst
Ord MinnettNot Ranked
Ord Minnett
AU$4
Buy
233.33%
Upside
Reiterated
04/29/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
AU$2.85
Buy
137.50%
Upside
Reiterated
12/08/25
Bell Potter
AU$2.3
Buy
91.67%
Upside
Reiterated
09/08/25
Bloom Burton
AU$4
Buy
233.33%
Upside
Reiterated
04/30/25
Unknown Analyst
Ord MinnettNot Ranked
Ord Minnett
AU$4
Buy
233.33%
Upside
Reiterated
04/29/25
Best Analysts Covering PYC Therapeutics Limited
3 Months
xxx
Success Rate
3/5 ratings generated profit
Average Return
+13.56%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +13.56% per trade.
1 Year
Success Rate
4/5 ratings generated profit
Average Return
+14.20%
a rating ―
Copying Thomas Wakim's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +14.20% per trade.
2 Years
xxx
Success Rate
4/5 ratings generated profit
Average Return
+19.38%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +19.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PYC Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
5
6
3
2
1
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
6
3
2
1
Each month's total comprises the sum of three months' worth of ratings.
PYC Financial Forecast
PYC Stock Forecast FAQ
What is AU:PYC’s average 12-month price target, according to analysts?
Based on analyst ratings, PYC Therapeutics Limited’s 12-month average price target is 2.85.
What is AU:PYC’s upside potential, based on the analysts’ average price target?
PYC Therapeutics Limited has 137.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PYC Therapeutics Limited a Buy, Sell or Hold?
PYC Therapeutics Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is PYC Therapeutics Limited’s share price target?
The average share price target for PYC Therapeutics Limited is 2.85. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$2.85 ,and the lowest forecast is AU$2.85. The average share price target represents 137.50% Increase from the current price of AU$1.2.
The highest analyst share price target is AU$2.85 ,and the lowest forecast is AU$2.85. The average share price target represents 137.50% Increase from the current price of AU$1.2.
What do analysts say about PYC Therapeutics Limited?
PYC Therapeutics Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of PYC Therapeutics Limited?
To buy shares of AU:PYC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.